Advances and controversies in management of breast ductal carcinoma in situ (DCIS).

Fecha de publicación: 01/04/2022 Fecha Ahead of Print: 09/11/2021

Autores de IIS La Fe

Juan José Vila Carbó

Autor
Francisco Ripoll Orts

Autor

Participantes ajenos a IIS La Fe

Farante G
Toesca A
Magnoni F
Lissidini G
Mastropasqua M
Viale G
Penco S
Cassano E
Lazzeroni M
Bonanni B
Leonardi MC
Curigliano G
Orecchia R
Galimberti V
Veronesi P

Grupos

Hepatología experimental y Trasplante hepático

Abstract

Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. It accounts for 25% of all breast cancers diagnosed, as a result of the expansion of breast cancer screening and is associated with a high survival rate. DCIS is particularly clinically challenging, due to its heterogeneous pathological and biological traits and its management is continually evolving towards more personalized and less aggressive therapies. This article suggests evidence-based guidelines for proper DCIS clinical management, which should be discussed within a multidisciplinary team in order to propose the most suitable approach in clinical practice, taking into account recent scientific studies. Here we include updated multidisciplinary treatment protocols and techniques in accordance with the most recent contributions published on this topic in the peer-reviewed medical literature, and we outline future perspectives.

Datos de la publicación

ISSN/ISSNe:: 0748-7983, 1532-2157
Tipo:: Article
Páginas:: 736-741
DOI:: 10.1016/j.ejso.2021.10.030
PubMed:: 34772587
Factor de Impacto:: 1,016 SCImago ℠
Cuartil:: Q1 SCImago ℠

Documentos

No hay documentos

Métricas

Filiaciones

Farante G:: Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Toesca A:: Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Magnoni F:: Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Lissidini G:: Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Vila J:: Hospital Universitario y Politécnico La Fe, Valencia, Spain
Mastropasqua M:: School of Medicine University of Bari "Aldo Moro", Italy
Viale G:: Division of Anatomo-Pathology, European Institute of Oncology (EIO), Milan, Italy

School of Medicine, University of Milan, Italy

Division of Anatomo-Pathology, European Institute of Oncology (EIO), Milan, Italy
Penco S:: Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Cassano E:: Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Lazzeroni M:: Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Bonanni B:: Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Leonardi MC:: Division of Radiotherapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Radiotherapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Ripoll-Orts F:: Hospital Universitario y Politécnico La Fe, Valencia, Spain
Curigliano G:: School of Medicine, University of Milan, Italy

Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Radiotherapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Early Drug Development for Innovative Therapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Radiotherapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Early Drug Development for Innovative Therapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Orecchia R:: School of Medicine, University of Milan, Italy

Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Radiotherapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Radiology, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Cancer Prevention and Genetics, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Radiotherapy, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Galimberti V:: Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy
Veronesi P:: Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

Hospital Universitario y Politécnico La Fe, Valencia, Spain

School of Medicine University of Bari "Aldo Moro", Italy

Division of Anatomo-Pathology, European Institute of Oncology (EIO), Milan, Italy

School of Medicine, University of Milan, Italy

Division of Breast Surgery, European Institute of Oncology (EIO), IRCCS, Milan, Italy

School of Medicine University of Bari "Aldo Moro", Italy

Division of Anatomo-Pathology, European Institute of Oncology (EIO), Milan, Italy

School of Medicine, University of Milan, Italy

Keywords

Breast cancer, Ductal carcinoma in situ, Guidelines, Medical treatment, Radiotherapy, Surgery

Campos de Estudio

Cita

Cita Bibliográfica